Canagliflozin impairs T cell effector function via metabolic suppression in autoimmunity-Reference-Cited by-同舟云学术

Canagliflozin impairs T cell effector function via metabolic suppression in autoimmunity

Published:2023-07 Issue:7 Volume:35 Page:1132-1146.e9
ISSN:1550-4131
Container-title:Cell Metabolism
language:en
Short-container-title:Cell Metabolism

Author:

Jenkins Benjamin J.,Blagih Julianna,Ponce-Garcia Fernando M.,Canavan Mary,Gudgeon Nancy,Eastham Simon,Hill David,Hanlon Megan M.,Ma Eric H.,Bishop Emma L.,Rees April,Cronin James G.,Jury Elizabeth C.,Dimeloe Sarah K.,Veale Douglas J.,Thornton Catherine A.,Vousden Karen H.,Finlay David K.,Fearon Ursula,Jones Gareth W.,Sinclair Linda V.,Vincent Emma E.,Jones Nicholas^ORCID

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Physiology

Reference51 articles.

1. Akt and STAT5 mediate naïve human CD4+ T cell early metabolic response to TCR stimulation;Jones;Nat. Commun.,2019

2. Rapid effector function of memory CD8+ T cells requires an immediate-early glycolytic switch;Gubser;Nat. Immunol.,2013

3. Metabolic adaptation of human CD4+ and CD8+ T cells to T cell receptor-mediated stimulation;Jones;Front. Immunol.,2017

4. Immunometabolism in early and late stages of rheumatoid arthritis;Weyand;Nat. Rev. Rheumatol.,2017

5. Type I interferons affect the metabolic fitness of CD8+ T cells from patients with systemic lupus erythematosus;Buang;Nat. Commun.,2021

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The alleviative effects of canagliflozin on imiquimod-induced mouse model of psoriasis-like inflammation;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-09-10

2. SGLT2 inhibitor promotes ketogenesis to improve MASH by suppressing CD8+ T cell activation;Cell Metabolism;2024-09

3. mTOR and SGLT-2 Inhibitors: Their Synergistic Effect on Age-Related Processes;International Journal of Molecular Sciences;2024-08-08

4. Could the administration of SGLT2i agents serve as a viable prophylactic approach against CNI-induced toxicities?;Medical Hypotheses;2024-08

5. SGLT-2 inhibitors: new horizons for rheumatologists;Current Opinion in Rheumatology;2024-07-16